Serveur d'exploration sur le lymphœdème - Curation (Ncbi)

Index « Mots-clés originaux en anglais » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : Keywords

Pour accéder à une entrée :

Les termes de plus forte occurence

11572Humans
6625Female
4496Male
4165Middle Aged
4103Adult
2787Aged
2757Lymphedema (etiology)
2542Animals
1559Adolescent
1368Lymphedema (therapy)
1226Lymphedema (diagnosis)
1178Child
1153Lymphedema (surgery)
1055Breast Neoplasms (surgery)
955Lymphedema (pathology)
911Lymphedema (complications)
869Aged, 80 and over
852Treatment Outcome
803Elephantiasis, Filarial (epidemiology)
777Lymphedema (diagnostic imaging)
771Leg
682Child, Preschool
666Follow-Up Studies
653Lymphedema (physiopathology)
634Arm
616Diagnosis, Differential
596Lymphedema
585Lymphography
582Elephantiasis, Filarial (prevention & control)
566Elephantiasis, Filarial (drug therapy)
549Chronic Disease
523Elephantiasis, Filarial (parasitology)
507Retrospective Studies
506Time Factors
489Risk Factors
489Infant
484Young Adult
470Breast Neoplasms (complications)
462Elephantiasis, Filarial (immunology)
456Lymph Node Excision (adverse effects)
436Prevalence
423Mastectomy (adverse effects)
421Lymphedema (prevention & control)
412Quality of Life
410Breast Neoplasms (pathology)
400Syndrome
382Lymphatic Metastasis
377Lymphedema (genetics)
377Lymphedema (epidemiology)
360Lymph Node Excision
350Breast Neoplasms (therapy)
344Axilla
342Prospective Studies
338Postoperative Complications
337Elephantiasis, Filarial (diagnosis)
336Wuchereria bancrofti
336Prognosis
323Combined Modality Therapy
321Surveys and Questionnaires
319Breast Neoplasms (radiotherapy)
312Elephantiasis, Filarial (transmission)
308Lymphedema (drug therapy)
308Diethylcarbamazine (therapeutic use)
307Mastectomy
303Neoplasm Staging
302Lymphedema (congenital)
301Mice
299Lymph Nodes (pathology)
299Filaricides (therapeutic use)
295Bandages
292Wuchereria bancrofti (isolation & purification)
288Elephantiasis
282Wuchereria bancrofti (immunology)
278Infant, Newborn
248Physical Therapy Modalities
245Radionuclide Imaging
231Skin Neoplasms (pathology)
231Lymphatic System (surgery)
216Cross-Sectional Studies
210Severity of Illness Index
208India (epidemiology)
208Disease Models, Animal
206Lower Extremity
204Lymphatic System (pathology)
200Methods
199Lymphoscintigraphy
199Incidence
199Drainage
198Leg (blood supply)
197Antigens, Helminth (immunology)
196Lymphedema (psychology)
193Lymph Node Excision (methods)
192Lymphatic System (physiopathology)
181Skin (pathology)
181Postoperative Complications (etiology)
180Pressure
178Sensitivity and Specificity
178Age Factors
177Radiotherapy (adverse effects)
176Dogs
172Lymphedema (rehabilitation)
172Elephantiasis (etiology)
170Tomography, X-Ray Computed
170Recurrence
169Veins (surgery)
169Lymphatic System (physiology)
168Edema (etiology)
166Microsurgery (methods)
166Lymph Nodes (surgery)
165Lymphedema (nursing)
164Elephantiasis, Filarial (pathology)
163Lymphatic Vessels (surgery)
163Diethylcarbamazine (administration & dosage)
161Elephantiasis, Filarial (blood)
158Biopsy
157Elephantiasis, Filarial (complications)
152Magnetic Resonance Imaging
151Radiography
150Reproducibility of Results
150Filaricides (administration & dosage)
149Rats
145Lymphography (methods)
145Brugia (immunology)
144Arm (pathology)
143Extremities
142Antigens, Helminth (blood)
141Lymph Nodes (diagnostic imaging)
140Enzyme-Linked Immunosorbent Assay
139Ivermectin (therapeutic use)
138Antibodies, Helminth (blood)
137Skin Transplantation
137Lymphedema (metabolism)
136Ultrasonography
135Edema
134Case-Control Studies
133Disease
132Lymph (physiology)
131Pregnancy
131Leg (surgery)
130Pedigree
130Lymphatic Vessels (pathology)
128Neoplasms (complications)
126Surgical Flaps
126Sentinel Lymph Node Biopsy
126Exercise Therapy
126Elephantiasis (pathology)
125India
124Microfilariae (isolation & purification)
123Leg (pathology)
121Drug Therapy, Combination
119Insect Vectors (parasitology)
119Brugia malayi (immunology)
118Hemangiosarcoma (pathology)
118Albendazole (therapeutic use)
117Phenotype
117Cohort Studies
115Phlebography
115Breast Neoplasms (psychology)
114Massage
114Lymphedema (classification)
114Lymph Nodes (transplantation)
111Filariasis (epidemiology)
110Endemic Diseases
109Patient Education as Topic
109Elephantiasis (diagnosis)
108Pilot Projects
108Edema (diagnosis)
107Postoperative Complications (prevention & control)
107Microsurgery
106Stockings, Compression
106Risk Assessment
106Postoperative Complications (epidemiology)
106Drainage (methods)
106Anastomosis, Surgical
105Predictive Value of Tests
104Transplantation, Autologous
104Lymphedema (immunology)
104Brugia
102Survivors
102Scrotum
102Culex (parasitology)
101Filariasis (immunology)
101Elephantiasis (surgery)
101Breast Neoplasms (rehabilitation)
101Anti-Bacterial Agents (therapeutic use)
101Anastomosis, Surgical (methods)
100Sex Factors
99Elephantiasis (epidemiology)
99Anthelmintics (therapeutic use)
98Immunohistochemistry
98Health Knowledge, Attitudes, Practice
97Microfilariae (immunology)
97Carcinoma, Squamous Cell (surgery)
96Wuchereria bancrofti (drug effects)
96Survival Rate
95Drug Administration Schedule
94Sentinel Lymph Node Biopsy (adverse effects)
94Postoperative Complications (therapy)
94Compression Bandages
92Leg (diagnostic imaging)
91Lymphangiosarcoma (etiology)
90Molecular Sequence Data
90Age Distribution
88Skin Neoplasms (surgery)
88Microfilariae
88Lymphangiosarcoma (pathology)
88Immunoglobulin G (blood)
87Uterine Cervical Neoplasms (surgery)
87Neoplasm Recurrence, Local
87Insect Vectors
86Postoperative Care
86Lymphatic Vessels (diagnostic imaging)
85Melanoma (surgery)
85Ivermectin (administration & dosage)
85Breast Neoplasms (drug therapy)
84Obesity (complications)
84Acute Disease
83Pain (etiology)
83Genital Diseases, Male (surgery)
83Double-Blind Method
82Postoperative Complications (surgery)
81Skin Neoplasms (etiology)
81Longitudinal Studies
81Edema (therapy)
81Arm (surgery)
81Antigens, Helminth (analysis)
80Upper Extremity
80Scrotum (surgery)
80Mutation
80Global Health
80Gerbillinae
79Skin Neoplasms (complications)
79Randomized Controlled Trials as Topic
79Lymphatic System (anatomy & histology)
79Body Mass Index
79Albendazole (administration & dosage)
78Reconstructive Surgical Procedures (methods)
78Postoperative Complications (diagnosis)
78Breast Neoplasms (mortality)
77Lymphangiogenesis (physiology)
77Cells, Cultured
77Axilla (surgery)
76Rural Population
76Electric Impedance
76Disease Progression
76Chyle
75Wound Healing
75Radiotherapy, Adjuvant (adverse effects)
75Mastectomy (methods)
74Vulvar Neoplasms (surgery)
74Neoplasm Metastasis
74Endemic Diseases (prevention & control)
73Range of Motion, Articular
73Hemangiosarcoma (etiology)
73Elephantiasis (therapy)
72Radiotherapy, Adjuvant
72Lymphatic System
72Feasibility Studies
71Survival Analysis
71Socioeconomic Factors
71Models, Biological
71Mastectomy, Segmental
71Fatal Outcome
71Adaptation, Psychological
69Mice, Inbred C57BL
69Elephantiasis, Filarial (therapy)
69Culicidae (parasitology)
69Coloring Agents
69Breast Neoplasms (physiopathology)
68Wuchereria bancrofti (genetics)
68Lymphatic System (abnormalities)
68Filariasis (complications)
68Contrast Media
68Breast Neoplasms (diagnosis)
67Lower Extremity (pathology)
67Eyelashes (abnormalities)
66Skin Neoplasms (diagnosis)
66Radiotherapy Dosage
66Disease-Free Survival
66Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
66Analysis of Variance
65Rabbits
65Penile Diseases (surgery)
65Patient Compliance
65Obesity, Morbid (complications)
65Lymphedema (chemically induced)
65Amino Acid Sequence
64Rural Health
64Lymphatic Vessels (physiology)
64Lymphatic Vessels (metabolism)
64Filariasis (drug therapy)
64Activities of Daily Living
63Lymphangiogenesis
63Groin
63Exercise
62Wuchereria bancrofti (growth & development)
62Indocyanine Green
62Chemotherapy, Adjuvant
62Arm (physiopathology)
62Amputation
61Vulvar Neoplasms (pathology)
61Technetium
61Logistic Models
61Filariasis (diagnosis)
61Equipment Design
61Clothing
60Venous Insufficiency (therapy)
60Radiopharmaceuticals
60Medical Records
60Coumarins (therapeutic use)
60Breast Neoplasms (diagnostic imaging)
59Vascular Endothelial Growth Factor Receptor-3 (genetics)
59Sentinel Lymph Node Biopsy (methods)
59Self Care
59Mice, Inbred BALB C
59Filariasis (parasitology)
59Diethylcarbamazine (adverse effects)
58Venous Insufficiency (complications)
58United Kingdom
58Microscopy, Electron
58Lymphatic Diseases (diagnostic imaging)
58Antibodies, Helminth (immunology)
57Survivors (psychology)
57Practice Guidelines as Topic
57Microfilariae (drug effects)
57Lymphatic Vessels (physiopathology)
57Edema (physiopathology)
57Base Sequence
57Arm (blood supply)
56Sex Distribution
56Anopheles (parasitology)
55Morbidity
54World Health Organization
54United States
54Physical Therapy Modalities (methods)
54Lymphocyte Activation
54Hemangiosarcoma (diagnosis)
54Comorbidity
54Arm (diagnostic imaging)
53Population Surveillance
53Nursing Assessment
53Elephantiasis (complications)
53Carcinoma, Squamous Cell (pathology)
52Uterine Cervical Neoplasms (pathology)
52Upper Extremity (pathology)
52Scrotum (pathology)
52Pleural Effusion (complications)
52Penis (surgery)
52Palliative Care
52Multivariate Analysis
52Magnetic Resonance Imaging (methods)
52Lymphangiosarcoma (diagnosis)
52Hand
52Angiography
51Nail Diseases (complications)
51Mosquito Control (methods)
51Melanoma (pathology)
51Lymphedema (blood)
51Exercise Therapy (methods)
51Ethiopia
51Attitude to Health
50Wuchereria bancrofti (physiology)
50Lymphatic Diseases (diagnosis)
50Inguinal Canal
50Hindlimb
50Carcinoma (surgery)
50Breast Neoplasms (epidemiology)
49Neoplasms (therapy)
49Leg Ulcer (etiology)
49Clinical Trials as Topic
49Abnormalities, Multiple (genetics)
48Venous Insufficiency (diagnosis)
48Social Support
48Onchocerciasis (drug therapy)
48Mastectomy, Radical
48Lymph Nodes (blood supply)
48Lipectomy
48Elephantiasis, Filarial (physiopathology)
48Elephantiasis, Filarial (diagnostic imaging)
48Anthelmintics (administration & dosage)
47Mastectomy, Radical (adverse effects)
47Genital Neoplasms, Female (surgery)
47Filariasis
47Elephantiasis, Filarial (economics)
47Developing Countries
47Cellulitis (etiology)
46T-Lymphocytes (immunology)
46Surgical Flaps (blood supply)
46Regression Analysis
46Preoperative Care
46Onchocerciasis (epidemiology)
46Lymphatic Metastasis (pathology)
46History, 20th Century
45Technetium Tc 99m Sulfur Colloid
45Skin (blood supply)
45Program Evaluation
45Penile Diseases (etiology)
45Onchocerciasis (prevention & control)
45Health Surveys
45Genotype
45Genetic Predisposition to Disease
45Forkhead Transcription Factors (genetics)
45Evidence-Based Medicine
45Carcinoma, Ductal, Breast (surgery)
44Lymphangioma (pathology)
44Erysipelas (complications)
44Enzyme-Linked Immunosorbent Assay (methods)
44Endometrial Neoplasms (surgery)
44Elephantiasis, Filarial (psychology)
44Edema (pathology)
44Edema (diagnostic imaging)
44Brugia malayi (isolation & purification)
44Algorithms
43Uterine Cervical Neoplasms (radiotherapy)
43Thrombophlebitis (complications)
43Technetium Tc 99m Aggregated Albumin
43Signal Transduction
43Postoperative Period
43Melanoma (secondary)
43Lymphatic Diseases (complications)
43Lymphangiogenesis (genetics)
43Filaricides (pharmacology)
43Filariasis (prevention & control)
43Fibrosis
43Brugia (isolation & purification)
43Biopsy, Needle
43Antibodies, Helminth (analysis)
42Venous Insufficiency (physiopathology)
42Tanzania (epidemiology)
42Reoperation
42Quality of Life (psychology)
42Patient Care Team
42Neoplasm Invasiveness
42Lymphatic Vessels (embryology)
42Lymphatic Metastasis (diagnosis)
42Immunity, Cellular
42Ethiopia (epidemiology)
42Endothelial Cells (metabolism)
42Dose-Response Relationship, Drug
42Antineoplastic Agents (adverse effects)
41Wuchereria bancrofti (pathogenicity)
41Polymerase Chain Reaction
41Mice, Knockout
41Lymphatic Metastasis (diagnostic imaging)
41Immunoglobulin G (immunology)
41Cost of Illness
40Thigh
40Testicular Hydrocele (epidemiology)
40Recombinant Proteins (immunology)
40Penile Neoplasms (surgery)
40Pelvis
40Mosquito Control
40Lymphatic Diseases (pathology)
40Lower Extremity (surgery)
40Diuretics (therapeutic use)
40Anthropometry
40Adenocarcinoma (surgery)
39Vascular Endothelial Growth Factor C (metabolism)
39Skin Diseases (pathology)
39Risk
39Regional Blood Flow
39Reference Values
39Qualitative Research
39Posture
39Postoperative Complications (diagnostic imaging)
39Patient Satisfaction
39Pain Measurement
39Lymphedema (parasitology)
39Lymphangitis (etiology)
39Hysterectomy
39Health Status
39Filaricides (adverse effects)
39Evaluation Studies as Topic
39Erysipelas (etiology)
39Cats
39Brugia (growth & development)
39Aedes (parasitology)
39Adipose Tissue (pathology)
38Wuchereria (immunology)
38Vascular Endothelial Growth Factor Receptor-3 (metabolism)
38Thrombophlebitis (diagnosis)
38Surgical Procedures, Operative
38Saphenous Vein (surgery)
38Radiation Injuries (etiology)
38Neoplasm Recurrence, Local (pathology)
38Malaria (prevention & control)
38Lymphedema (veterinary)
38Haiti (epidemiology)
38Filariasis (pathology)
38Disease Vectors
38China (epidemiology)
37Sarcoma, Kaposi (pathology)
37Public Health
37Postoperative Complications (physiopathology)
37Organ Size
37Mice, Transgenic
37Massage (methods)
37Ivermectin (adverse effects)
37Brugia malayi (genetics)
37Blotting, Western

Manipulations en shell (Unix/Dilib)

HfdCat /applis/lorexplor/Wicri/Sante/explor/Lymphedema.storage/LymphedemaV1.20171104/Data/Ncbi/Curation/KwdEn.i.hfd| SxmlCut idx/l | grep ...  

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024